^○Seiji Miyauchi ¹, Masayuki Masuda ¹, Yuudai Tanaka ¹, Shouko Iwakado ¹, Kazumi Shimono ², Soo-Jin Kim ², Yuichi Sugiyama ² (1.Faculty of Pharmaceutical Sciences, Toho University, 2.RIKEN Research Cluster for Innovation, RIKEN)

^○Yuya Tsurudome ¹, Satoru Koyanagi ¹, Masayuki Oda ², Takumi Kanemitsu ¹, Yuki Kanado ¹, Mizuki Kato ¹, Naoya Matsunaga ¹, Shigehiro Ohdo ¹ (1.Department of Pharmaceutics. Graduate School of Pharmaceutics Science, Kyushu University, 2.Department of Pharmacogenomics, St. Marianna University Graduate School of Medicine)

^○Hiroaki Miura , Ayaka Tomise , Shin-ichi Akanuma , Yoshiyuki Kubo , Ken-ichi Hosoya (Graduate School of Medicine and Pharmaceutical Scineces, University of Toyama)

^○Yoshihisa Mimura ¹, Tomoya Yasujima ¹, Kinya Ohta ¹, Katsuhisa Inoue ², Hiroaki Yuasa ¹ (1.Graduate School of Pharmaceutical Sciences, Nagoya City University, 2.School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)

^○Carsten Ehrhardt ¹, Sabrina Nickel ¹, Mohammed Ali Selo ¹, Caoimhe G. Clerkin ¹, Paul R. Reynolds ², Yukio Kato ³, Noritaka Nakamichi ³, Brian N. Talbot ¹, John J. Walsh ¹ (1.School of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Scienc es Institute, Trinity College Dublin, 2.Physiology & Developmental Biology, The College of Life Sciences, Brigham Young University, Provo, 3.Laboratory of Molecular Pharmacotherapeutics Faculty of Pharmcy, Kanazawa University)

^○Misa Nishiyama , Noritaka Nakamichi , Yusuke Masuo , Yukio Kato (Faculty of Pharmacy, Kanazawa University)

^○Tomohisa Nakada ¹, Kazuaki Ikejiri ², Kota Toshimoto ³, Kei Ogawa ¹, Noriko Hisanaga ¹, Hiroyuki Kusuhara ², Kazuya Maeda ², Yuichi Sugiyama ³ (1.DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, 2.Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 3.Sugiyama Laboratory, RIKEN Innovation Center, Research Cluster for Innovation, RIKEN)